Impact of Low Body Mass Index on Cardiac Tamponade During Catheter Ablation for Atrial Fibrillation
- PMID: 36858686
- DOI: 10.1016/j.jacep.2022.08.025
Impact of Low Body Mass Index on Cardiac Tamponade During Catheter Ablation for Atrial Fibrillation
Abstract
Background: Cardiac tamponade is a potentially fatal complication of catheter ablation for atrial fibrillation (AF).
Objectives: This study aimed to evaluate the impact of body mass index (BMI) on cardiac tamponade during AF ablation.
Methods: Patients who underwent catheter ablation for AF between April 1, 2016 and March 31, 2018 were analyzed using a Japanese nationwide claims database. Mixed-effects multivariable Poisson regression analysis was performed to investigate the association between BMI and cardiac tamponade.
Results: A total of 59,789 hospitalizations (age 65.6 ± 10.4 years, 29% women) with catheter ablation for AF were analyzed. Cardiac tamponade occurred in 647 patients (1.1%). Multivariable analysis revealed that being underweight (BMI <18.5 kg/m2) was associated with an increased risk of cardiac tamponade (relative risk [RR]: 1.42; 95% CI: 1.03-1.95) when compared with having a normal weight (BMI ≥18.5 and <25 kg/m2). Other characteristics that were associated with an increased risk of cardiac tamponade were age ≥75 years, female sex, and a history of heart failure, hypertension, diabetes, and dialysis treatment.
Conclusions: In this analysis of a large nationwide database of patients with AF who underwent ablation, being underweight was independently associated with an increased risk of cardiac tamponade during AF ablation. Clinicians should consider the higher risk of cardiac tamponade in the underweight population and take appropriate measures to reduce this risk.
Keywords: Japanese Registry of All Cardiac and Vascular Diseases; atrial fibrillation; body mass index; cardiac tamponade; catheter ablation; nationwide database.
Copyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures This work was supported by the Ministry of Health, Labor and Welfare Scientific Research Grant for the Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus (grant 19FA1601) and Intramural Research Fund (21-6-9) for Cardiovascular Diseases of National Cerebral and Cardiovascular Center. Dr Kusano has received speaker honoraria and research grants from Medtronic Japan. Dr Yamane has received speaker honoraria and research grants from Medtronic Japan and Abbott Medical Japan. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
